{
  "meta": {
    "title": "23_Drugs_For_Parkinson_S_Disease",
    "url": "https://brainandscalpel.vercel.app/23-drugs-for-parkinson-s-disease-7bac38ff.html",
    "scrapedAt": "2025-11-30T12:34:12.758Z"
  },
  "questions": [
    {
      "text": "Which of the following drugs crosses the blood-brain barrier?",
      "choices": [
        {
          "id": 1,
          "text": "Dopamine"
        },
        {
          "id": 2,
          "text": "Levodopa"
        },
        {
          "id": 3,
          "text": "Both A and B"
        },
        {
          "id": 4,
          "text": "Carbidopa"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Levodopa crosses</strong> the <strong>blood-brain barrier.</strong></p>\n<p>It is a naturally occurring aromatic amino acid and an<strong> immediate precursor</strong> of<strong> dopamine </strong>that can cross the blood-brain barrier.<strong>&nbsp;</strong>Dopamine does not cross the blood-brain barrier because of the polar nature of the molecule. Levodopa is also a <strong>polar compound</strong> but it can cross the blood-brain barrier through an <strong>aromatic amino acid transporter.</strong></p>\n<p>Therefore, levodopa is used <strong>therapeutically</strong> when <strong>dopamine</strong> is required for <strong>central action.</strong> Levodopa is converted to dopamine by the decarboxylase enzyme.</p>\n<p><strong>Carbidopa</strong> is a peripheral decarboxylase inhibitor and does not penetrate the blood-brain barrier.</p><hr><h3>Related Pearl: Neurotransmitters in Psychiatry</h3><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Neurotransmitter</strong></div>\n</td>\n<td>\n<div><strong>Source</strong></div>\n</td>\n<td>\n<div><strong>Disorder</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Dopamine</strong></div>\n&nbsp;</td>\n<td>\n<div>&nbsp;</div>\n<div>Substantia Nigra</div>\n&nbsp;</td>\n<td>\n<div><strong>Decrease</strong>:</div>\n<div>Parkinson&rsquo;s disease</div>\n<div>\n<div><strong>Increase</strong>:&nbsp;</div>\n<div>Mania, Delirium</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Acetylcholine</strong></div>\n&nbsp;&nbsp;</td>\n<td>\n<div>Nucleus Basalis (of Meynert)</div>\n&nbsp;&nbsp;</td>\n<td>\n<div><strong>Decrease</strong>:</div>\n<div>Delirium, Dementia</div>\n<div>\n<div><strong>Increase</strong>:</div>\n<div>Parkinson&rsquo;s disease</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong>Norepinephrine</strong></td>\n<td>Locus Coeruleus</td>\n<td>\n<div>\n<div>\n<div><strong>Decrease</strong>:</div>\n<div>Depression</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong>Serotonin</strong></td>\n<td>Midline Raphe nucleus</td>\n<td>\n<div>\n<div>\n<div>\n<div><strong>Decrease</strong>:</div>\n<div>Depression</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2851",
      "difficulty": "medium"
    },
    {
      "text": "A 55-year-old is diagnosed with Parkinson's disease and is started on levodopa therapy. Which of the following statements is incorrect about the drug?",
      "choices": [
        {
          "id": 1,
          "text": "In parkinsonism, phenothiazines reduce its efficacy"
        },
        {
          "id": 2,
          "text": "It is a prodrug"
        },
        {
          "id": 3,
          "text": "Pyridoxine reduces effect of levodopa in parkinsonism"
        },
        {
          "id": 4,
          "text": "Domperidone reduces levodopa induced emesis and its therapeutic potential"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Domperidone</strong> is an <strong>antidopaminergic</strong> antiemetic that can <strong>reverse</strong> levodopa-induced <strong>emesis without affecting</strong> the<strong> therapeutic potential </strong>as it cannot cross the blood-brain barrier.</p>\n<p>The <strong>antiemetic effect</strong> is through its action on <strong>CTZ</strong> which is outside the blood-brain barrier.</p>\n<p>Option A: Typical antipsychotics like phenothiazines can reduce the efficacy of levodopa because of its central D2 blocking property.</p>\n<p>Option B: Levodopa is a prodrug. It is converted into dopamine by the decarboxylase enzyme in CNS.</p>\n<p>Option C: Pyridoxine can reduce the effect of levodopa by increasing its peripheral conversion to dopamine by potentiating peripheral dopa decarboxylase enzyme.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2884",
      "difficulty": "medium"
    },
    {
      "text": "After initiation of levodopa therapy, a 55-year-old patient starts experiencing adverse effects. Which of these side effects is not decreased by the addition of carbidopa?",
      "choices": [
        {
          "id": 1,
          "text": "Nausea and vomiting"
        },
        {
          "id": 2,
          "text": "On and off effect"
        },
        {
          "id": 3,
          "text": "Cardiac arrhythmias"
        },
        {
          "id": 4,
          "text": "Hallucinations"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Behavioral adverse effects</strong> like confusion, hallucinations, nightmares, delusions, postural hypotension are <strong>not reduced </strong>after the addition of carbidopa<strong>.</strong></p>\n<p>In fact, they are <strong>increased</strong>&nbsp;in patients who are taking levodopa with<strong> peripheral decarboxylase</strong> inhibitors.<strong>&nbsp;</strong>This is because <strong>higher</strong> levels of <strong>dopamine</strong> are formed in CNS.</p>\n<p>The combination of levodopa with peripheral decarboxylase inhibitors like carbidopa inhibits peripheral adverse effects of dopamine. This decreases the adverse effects like:</p>\n<ul>\n<li>Anorexia, nausea, and vomiting&nbsp;</li>\n<li>Cardiac arrhythmias</li>\n<li>On and off effect of motor performance</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2887",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old male is brought to the casualty in a confused state. On examination, he has severe muscle rigidity. His son says that the patient is on treatment for Parkinson's disease but has forgotten to take his medication as they went on a holiday trip. What is the likely diagnosis in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Wearing off phenomenon"
        },
        {
          "id": 2,
          "text": "On / Off phenomenon"
        },
        {
          "id": 3,
          "text": "Neuroleptic malignant syndrome"
        },
        {
          "id": 4,
          "text": "Serotonin syndrome"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Abrupt withdrawal of levodopa </strong>or dopaminergic agonists&nbsp;can<strong> precipitate neuroleptic malignant syndrome.</strong>&nbsp;It<strong>&nbsp;</strong>is&nbsp;characterized by extreme rigidity, confusion, and hyperthermia.&nbsp;</p>\n<p>It is an <strong>emergency</strong> condition that can turn <strong>fatal</strong> if immediate intervention is not done. Neuroleptic malignant syndrome is commonly associated with the use of <strong>typical antipsychotics.</strong></p>\n<p>Option A:<strong> Wearing off phenomenon -&nbsp;</strong>Each dose of levodopa improves mobility for a period of 1-2 hours. After that, the effect of the drug wears off, and rigidity and akinesia return. This can be surpassed by increasing the dosing and frequency.</p>\n<p>Option B:<strong> On/off phenomenon -&nbsp;</strong>Rapid fluctuation between on and off periods.</p>\n<ul>\n<li>On period: When the patient has a beneficial effect of the medications but with disabling dyskinesias</li>\n<li>Off period: No beneficial effects from anti-Parkinsonism medications.</li>\n</ul>\n<p>'Wearing off' and 'On / Off' phenomenon occur with long-term treatment of levodopa.</p>\n<p>Option D:&nbsp;Serotonin syndrome occurs with co-prescription of MAO-inhibitors and SSRIs.&nbsp;</p><hr><h3>Related Pearl: Psychiatric emergency: Fever with altered mental status</h3><p>In a clinical setting of <strong>fever with altered mental status</strong>, it is important to differentiate between the following.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>&nbsp;Syndrome</strong></span></div>\n</td>\n<td>\n<div><span><strong>Neuroleptic malignant syndrome</strong></span></div>\n</td>\n<td>\n<div><span><strong>Serotonin syndrome</strong></span></div>\n</td>\n<td>\n<div><span><strong>Anticholinergic syndrome</strong></span></div>\n</td>\n<td>\n<div><span><strong>Malignant hyperthermia</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>&nbsp;Cause</strong></span></div>\n</td>\n<td>\n<div><span>Dysregulation of dopaminergic pathways</span></div>\n</td>\n<td>\n<div><span>Co-prescription of MAO-I and SSRIs leading to increased serotonin and norepinephrine levels</span></div>\n</td>\n<td>\n<div>\n<div><span>Anticholinergic i</span><span>ntoxication</span></div>\n</div>\n</td>\n<td>\n<div>\n<div><span>Halogenated anesthetics and succinylcholine leading to a</span></div>\n</div>\n<div><span>hypermetabolic response causing an increased intracellular calcium level</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Fever and altered mental status</strong></span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Muscle tone</strong></span></div>\n</td>\n<td>\n<div><span>Rigid</span></div>\n</td>\n<td>\n<div><span>Rigid</span></div>\n</td>\n<td>\n<div><span><strong>Normal</strong></span></div>\n</td>\n<td>\n<div><span>Rigid</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Skin and mucosa</strong></span></div>\n</td>\n<td>\n<div><span>Wet</span></div>\n</td>\n<td>\n<div><span>Wet</span></div>\n</td>\n<td>\n<div><strong><span>Dry</span></strong></div>\n</td>\n<td>\n<div><span>Wet</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Pupils</strong></span></div>\n</td>\n<td>\n<div><span>Normal</span></div>\n</td>\n<td>\n<div><span><strong>Dilated</strong></span></div>\n</td>\n<td>\n<div><span><strong>Dilated</strong></span></div>\n</td>\n<td>\n<div><span>Normal</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Bowel sounds</strong></span></div>\n</td>\n<td>\n<div><span>Normal</span></div>\n</td>\n<td>\n<div><span>Increased</span></div>\n</td>\n<td>\n<div><span>Decreased</span></div>\n</td>\n<td>\n<div><span>Decreased</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Reflexes</strong></span></div>\n</td>\n<td>\n<div><span>Bradyreflexia</span></div>\n</td>\n<td>\n<div><span>Increased</span></div>\n</td>\n<td>\n<div><span>Normal</span></div>\n</td>\n<td>\n<div><span>Decreased</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Treatment</strong></span></div>\n</td>\n<td>\n<div><span>Stop antipsychotic;</span></div>\n<div><span>give dantrolene, bromocriptine and&nbsp;</span><span>monitor CPK levels</span></div>\n</td>\n<td>\n<div><span>Change the drug;&nbsp;</span></div>\n<div><span>give cyproheptadine</span></div>\n</td>\n<td>\n<div><span>Discontinue drug;</span></div>\n<div><span>give i.v. physostigmine</span></div>\n</td>\n<td>\n<div><span>Cooling, dantrolene, insulin, and glucose</span></div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2882",
      "difficulty": "hard"
    },
    {
      "text": "A patient on long-term treatment with levodopa and carbidopa for Parkinson's disease is diagnosed with on/off phenomenon. Which of the following drugs is used to treat this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Safinamide"
        },
        {
          "id": 2,
          "text": "Amantadine"
        },
        {
          "id": 3,
          "text": "Benztropine"
        },
        {
          "id": 4,
          "text": "Domperidone"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Safinamide</strong> is used for the treatment of the <strong>on/off phenomenon</strong>.</p>\n<p>Management of On/Off phenomenon:</p>\n<ul>\n<li>To prolong the 'On' phase:\n<ul>\n<li>COMT inhibitor - entacapone, tolcapone</li>\n<li>Irreversible MAO-B inhibitor - selegiline, rasagiline</li>\n<li>Reversible MAO-B inhibitor - safinamide.</li>\n</ul>\n</li>\n<li>Rescue from 'Off' phase: injection <strong>apomorphine</strong></li>\n</ul>\n<p>Dopaminergic agonists like pramipexole, ropinirole, and rotigotine are also effective in the treatment of the on/off phenomenon.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6938",
      "difficulty": "medium"
    },
    {
      "text": "A patient who is on levodopa therapy presents with confusion, delusions of grandeur, and hallucinations. What is the most appropriate treatment for his condition?",
      "choices": [
        {
          "id": 1,
          "text": "Haloperidol"
        },
        {
          "id": 2,
          "text": "Chlorpromazine"
        },
        {
          "id": 3,
          "text": "Trifluperazine"
        },
        {
          "id": 4,
          "text": "Quetiapine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario is suggestive of<strong> levodopa-induced psychosis </strong>for which<strong> quetiapine </strong>is the most appropriate treatment.</p>\n<p><strong>Quetiapine</strong> and <strong>clozapine</strong> are the two atypical antipsychotics that are most effective and best tolerated in levodopa-induced psychosis<strong>.&nbsp;</strong></p>\n<p><strong>Typical antipsychotics&nbsp;</strong>are effective against levodopa-induced psychosis but may cause marked <strong>worsening of parkinsonism</strong>. Hence, atypical antipsychotics are deemed safer.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2883",
      "difficulty": "hard"
    },
    {
      "text": "While discharging a patient with Parkinson's disease, the treating physician writes a prescription of levodopa along with another drug that can increase the bioavailability of the former. Identify the drug.",
      "choices": [
        {
          "id": 1,
          "text": "Entacapone"
        },
        {
          "id": 2,
          "text": "Ropinirole"
        },
        {
          "id": 3,
          "text": "Amantadine"
        },
        {
          "id": 4,
          "text": "Apomorphine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Entacapone </strong>is a <strong>peripheral COMT inhibitor </strong>that <strong>increases</strong> the <strong>bioavailability</strong> of <strong>levodopa.</strong></p>\n<p>It <strong>inhibits</strong> the peripheral <strong>metabolism</strong> of levodopa thereby increasing the bioavailability of levodopa.<strong>&nbsp;&nbsp;</strong></p>\n<p>Options B and D: Ropinirole and apomorphine are dopamine receptor agonists and do not have any significant effect on levodopa bioavailability.</p>\n<p>Option C: Amantadine which is an antiviral drug is also anti-Parkinsonian due to its varied actions including increased release and decreased uptake of dopamine. It has no significant effect on the bioavailability of levodopa.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1842",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following anti-Parkinsonism drugs is correctly matched with its mechanism of action?",
      "choices": [
        {
          "id": 1,
          "text": "Tolcapone - COMT inhibition"
        },
        {
          "id": 2,
          "text": "Rasagiline - Muscarinic antagonism"
        },
        {
          "id": 3,
          "text": "Amantidine - MAO-B inhibition"
        },
        {
          "id": 4,
          "text": "Apomorphine - Inhibition of dopa"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Tolcapone </strong>and<strong> entacapone </strong>are selective, potent, and reversible <strong>COMT </strong>(catechol-O-methyl transferase) <strong>inhibitors.</strong></p>\n<p>COMT metabolizes levodopa and blockade of this pathway prolongs the half-life of levodopa and allows a larger fraction of the administered dose to reach the brain.</p>\n<p>Option B: Rasagiline is a selective MAO-B inhibitor.</p>\n<p>Option C: Amantadine acts by antagonism of the NMDA type of glutamate receptors.</p>\n<p>Option D:&nbsp;<span>Apomorphine is a dopaminergic agonist that&nbsp;</span>is FDA-approved as a 'rescue therapy' for the acute intermittent treatment of 'off' episodes.</p><hr><h3>Related Pearl: Medical treatment of Parkinson's disease</h3><table>\n<tbody>\n<tr>\n<td><strong>Increase dopaminergic action</strong></td>\n<td><strong>Anti cholinergics</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Dopamine precursor</strong><strong>&nbsp; &nbsp; &nbsp; &nbsp;</strong></p>\n</td>\n<td><strong>Anti muscarinic </strong></td>\n</tr>\n<tr>\n<td>Levodopa</td>\n<td>Benzhexol (trihexyphenidyl)</td>\n</tr>\n<tr>\n<td><strong>Dopa decarboxylase inhibitor </strong></td>\n<td>Benztropine</td>\n</tr>\n<tr>\n<td>Carbedopa</td>\n<td>Procyclidine</td>\n</tr>\n<tr>\n<td>Benserazide</td>\n<td><strong>H1 antagonist </strong></td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Ergot derivatives</strong></td>\n<td>Promethazine</td>\n</tr>\n<tr>\n<td>Bromocriptine</td>\n<td>Orphenadrine</td>\n</tr>\n<tr>\n<td>Cabergoline</td>\n<td>Diphenhydramine</td>\n</tr>\n<tr>\n<td>Pergolide</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Lisuride</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Non ergot&nbsp;derivatives</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Ropinirole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Pramipexole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rotigotine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Apomorphine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine facilitator </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Amantadine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>MAO-B inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Selegiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rasagiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>COMT inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Tolcapone</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Entacapone</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2894",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is false regarding the use of selegiline in Parkinsonism?",
      "choices": [
        {
          "id": 1,
          "text": "It acts as a selective MAO A inhibitor"
        },
        {
          "id": 2,
          "text": "Incidence of cheese reaction is minimal"
        },
        {
          "id": 3,
          "text": "May be used for on / off phenomenon"
        },
        {
          "id": 4,
          "text": "It forms amphetamines as metabolites"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Selegiline </strong>acts as a selective<strong> MAO-B inhibitor.</strong></p>\n<p>At <strong>higher doses, MAO-A</strong> can also be <strong>inhibited.</strong> Higher doses are used for depression and administered in the form of the <strong>transdermal patch.</strong>&nbsp;</p>\n<p>Option B: Selective MAO-B inhibitors do not interfere significantly with the peripheral metabolism of dietary amines and do not cause cheese reaction.</p>\n<p>Option C: &nbsp;It has lower efficacy than levodopa but when added with levodopa it prolongs its action and also decreases the wearing-off effect of levodopa.</p>\n<p>Option D:&nbsp;Selegiline forms metabolites like amphetamine and methamphetamine that can result in anxiety, insomnia, and other undesirable effects.&nbsp;<strong>Rasagiline</strong>, unlike selegiline, <strong>does not</strong> form amphetamines as metabolites.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2893",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following dopamine agonists is an ergot derivative?<div class='question-desc-html'><ol>\n<li>Bromocriptine</li>\n<li>Pergolide</li>\n<li>Ropinirole</li>\n<li>Rotigotine</li>\n<li>Pramipexole</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "3, 4 and 5"
        },
        {
          "id": 2,
          "text": "1, 2 and 3"
        },
        {
          "id": 3,
          "text": "1 and 2"
        },
        {
          "id": 4,
          "text": "4 and 5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Bromocriptine </strong>and <strong>pergolide</strong> are&nbsp;<strong>ergot derivatives</strong> that act as potent <strong>agonists</strong> at the <strong>D<sub>2</sub> receptor</strong>.</p>\n<p>Pramipexole and ropinirole are non-ergot derivatives having D<sub>2</sub>/D<sub>3 </sub>receptor agonistic action. They are better tolerated and have fewer GI symptoms than bromocriptine.</p>\n<p>Dopamine agonists can be classified as follows:</p>\n<ul>\n<li>Ergot derivatives - Bromocriptine, pergolide, cabergoline</li>\n<li>Non-ergot derivatives -&nbsp;<strong>Pramipexole</strong>, <strong>ropinirole</strong>, apomorphine, <strong>rotigotine</strong></li>\n</ul>\n<p>Dopaminergic agonists exert subtype-selective activation of dopaminergic receptors involved in the Parkinsonism circuit of the striatum.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2885",
      "difficulty": "medium"
    },
    {
      "text": "A 50-year-old female patient visits the OPD with complaints of burning sensation associated with an irresistible urge to move her legs since 2 weeks. It occurs especially at night and the discomfort gets relieved on moving her legs. Which is the first-line drug that can be prescribed for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Benztropine"
        },
        {
          "id": 2,
          "text": "Gabapentin"
        },
        {
          "id": 3,
          "text": "Riluzole"
        },
        {
          "id": 4,
          "text": "Clonazepam"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The symptoms in this patient are suggestive of<strong> restless leg syndrome </strong>and <strong>gabapentin</strong> is the first-line choice of treatment for this condition.&nbsp; &nbsp;<strong>&nbsp;</strong></p>\n<p>Restless leg syndrome is a typical <strong>sensory-motor disorder</strong> that generally affects the legs during rest periods, especially sleep. There is an <strong>irresistible urge</strong> to<strong> shake</strong> the<strong> legs</strong> associated with <strong>burning sensation, itching,</strong> and <strong>cramps</strong> of the legs. In idiopathic cases, dopaminergic hypofunction is postulated.</p>\n<p>In patients with restless legs syndrome, iron stores are initially repleted, and the aggravating factors are eliminated. If RLS still persists, initial therapy with a gabapentinoid (pregabalin, gabapentin, gabapentin enacarbil) are preferred, rather than a dopamine agonist (pramipexole, ropinirole, rotigotine). This is due to the high frequency of intermediate and long-term augmentation with dopamine agonists, as well as their risk of impulse control disorders.</p>\n<p><strong>FDA-approved</strong> drugs for the <strong>treatment</strong> of restless leg syndrome:&nbsp;</p>\n<ul>\n<li>Gabapentin</li>\n<li>Ropinirole</li>\n<li>Pramipexole</li>\n<li>Rotigotine&nbsp;</li>\n</ul>\n<p>A dopamine agonist is used as an alternative in patients with increased risk for side effects from gabapentinoids, such as those with obesity and its complications, a past or present history of moderate to severe depression, a disorder causing gait instability or respiratory failure, and a history of substance use disorder.</p>\n<p>Option A:<span data-preserver-spaces=\"true\">&nbsp;</span><strong><span data-preserver-spaces=\"true\">Benztropine</span></strong><span data-preserver-spaces=\"true\">&nbsp;is an anticholinergic that can be used for&nbsp;</span><strong><span data-preserver-spaces=\"true\">drug-induced parkinsonism</span></strong><span data-preserver-spaces=\"true\">.&nbsp;</span></p>\n<p>Option C: <strong>Riluzole</strong> is a benzothiazole derivative that is used in <strong>amyotrophic lateral sclerosis.</strong></p>\n<p>Option D: Benzodiazepines like <strong>clonazepam</strong> can be used as <strong>co-adjuvant</strong> drugs in the treatment of <strong>restless leg syndrome</strong> but should <strong>not</strong> be used as <strong>first-line</strong> therapy.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2886",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following dopamine receptor agonists has antioxidant properties?",
      "choices": [
        {
          "id": 1,
          "text": "Bromocriptine"
        },
        {
          "id": 2,
          "text": "Pergolide"
        },
        {
          "id": 3,
          "text": "Pramipexole"
        },
        {
          "id": 4,
          "text": "Ropinirole"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Pramipexole</strong> is a <strong>dopamine receptor agonist</strong> that has an additional <strong>antioxidant effect.&nbsp;</strong></p>\n<p>Pramipexole has a possible <strong>neuroprotective</strong> effect by its ability to scavenge hydrogen peroxide and enhance neurotrophic activity.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1843",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following drugs would you prescribe as a transdermal patch to patients with Parkinson’s disease?",
      "choices": [
        {
          "id": 1,
          "text": "Selegiline"
        },
        {
          "id": 2,
          "text": "Rotigotine"
        },
        {
          "id": 3,
          "text": "Entacapone"
        },
        {
          "id": 4,
          "text": "Apomorphine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Rotigotine </strong>is a dopamine agonist used in <strong>Parkinson&rsquo;s disease</strong> as a<strong> transdermal patch.</strong></p>\n<p>A transdermal patch can lead to various <strong>local reactions</strong> at the application site. Rotigotine was withdrawn from some markets due to crystal formation on the patch but later reintroduced with a newer formulation.</p>\n<p>Selegiline transdermal patch is approved for depression and not for Parkinson&rsquo;s disease.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2889",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old female is on treatment with ropinirole for restless leg syndrome. Which of the following adverse effects are not expected to be seen in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Drowsiness"
        },
        {
          "id": 2,
          "text": "Postural hypotension"
        },
        {
          "id": 3,
          "text": "Cardiac fibrosis"
        },
        {
          "id": 4,
          "text": "Hallucination"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Cardiac fibrosis</strong> is a side effect of <strong>pergolide,</strong> not&nbsp;ropinirole.&nbsp;</p>\n<p>The <strong>adverse effects</strong> of <strong>ropinirole</strong> include:&nbsp;</p>\n<ul>\n<li>Nausea</li>\n<li>Drowsiness</li>\n<li>Postural hypotension</li>\n<li>Hallucinations</li>\n</ul>\n<p><strong>Cardiac </strong>and<strong> pleural fibrosis </strong>are seen with<strong> pergolide </strong>which is also a dopamine agonist. Pergolide was <strong>withdrawn</strong> from the market due to reports of serious valve damage.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2897",
      "difficulty": "medium"
    },
    {
      "text": "Which anti-Parkinsonism drug is an NMDA-glutamate receptor antagonist?",
      "choices": [
        {
          "id": 1,
          "text": "Amantadine"
        },
        {
          "id": 2,
          "text": "Rotigotine"
        },
        {
          "id": 3,
          "text": "Benzhexol"
        },
        {
          "id": 4,
          "text": "Trihexyphenidyl"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Amantadine </strong>which&nbsp;is an antiviral agent, also used in parkinsonism&nbsp;has<strong> NMDA glutamate receptor antagonist action.&nbsp;</strong></p>\n<p>This action&nbsp;is responsible for its <strong>antidyskinetic</strong> properties. It also promotes presynaptic synthesis and release of dopamine.&nbsp;</p>\n<p>Option B: Rotigotine is a dopamine agonist available as a transdermal patch.</p>\n<p>Options C and D: Benzhexol and trihexyphenidyl are central anticholinergics.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2890",
      "difficulty": "easy"
    },
    {
      "text": "A 55-year-old patient presents to the dermatology OPD with findings as shown in the image below. Which of the following drugs can result in this adverse effect?",
      "choices": [
        {
          "id": 1,
          "text": "Pergolide"
        },
        {
          "id": 2,
          "text": "Memantine"
        },
        {
          "id": 3,
          "text": "Amantadine"
        },
        {
          "id": 4,
          "text": "Trihexyphenidyl"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The above presentation is of <strong>livedo reticularis</strong>, which is an adverse effect of <strong>amantadine</strong>.</p>\n<p>The patient presents with a common skin finding consisting of a <strong>mottled vesicular pattern</strong> that appears as a <strong>lace-like purplish discoloration</strong> of the skin which is<strong>&nbsp;</strong>due to the <strong>local release</strong> of <strong>catecholamines</strong> resulting in post-capillary vasoconstriction.</p>\n<p>Adverse effects of amantadine are:</p>\n<ul>\n<li>Insomnia, restlessness, confusion</li>\n<li>Nightmares</li>\n<li>Anticholinergic effects</li>\n<li>Hallucinations&nbsp;</li>\n<li>Livedo reticularis</li>\n<li>Edema of ankles</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/c4889023d4b04e79ad939c5bed8f8810.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2899",
      "difficulty": "easy"
    },
    {
      "text": "Which is the 5HT2A inverse agonist approved for use in psychosis associated with Parkinsonism?",
      "choices": [
        {
          "id": 1,
          "text": "Lorcaserin"
        },
        {
          "id": 2,
          "text": "Pimavanserin"
        },
        {
          "id": 3,
          "text": "Pitolisant"
        },
        {
          "id": 4,
          "text": "Mianserin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Pimavanserin </strong>is a <strong>selective 5-HT2A receptor inverse agonist</strong> that is approved for the management of&nbsp;<strong>delirium</strong> and<strong> hallucinations </strong>associated with<strong> Parkinson's disease.</strong></p>\n<p>Option A: Lorcaserin is a 5-HT2C agonist indicated as an anti-obesity agent.&nbsp;</p>\n<p>Option C: Pitolisant is an H3 receptor inverse agonist&nbsp;approved for the treatment of&nbsp;narcolepsy.</p>\n<p>Option D: Mianserin is an anti-depressant.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1863",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old male patient presented to the casualty department with bradykinesia, rigidity, and tremors. His attender reported that he had been diagnosed with schizophrenia and had recently started treatment.  What is the drug of choice to treat the patient's presenting symptoms?",
      "choices": [
        {
          "id": 1,
          "text": "Levodopa"
        },
        {
          "id": 2,
          "text": "Benzhexol"
        },
        {
          "id": 3,
          "text": "Amantadine"
        },
        {
          "id": 4,
          "text": "Selegiline"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of<strong>&nbsp;</strong><strong>drug-induced parkinsonism,</strong>&nbsp;for which the drug of choice<strong>&nbsp;</strong>is<strong> benzhexol,&nbsp;</strong>also known as <strong>trihexiphenidyl</strong>.&nbsp;</p>\n<p>Drug-induced parkinsonism is caused by certain drugs that have D<sub>2</sub> antagonistic action, such as typical antipsychotics. Due to the decrease in dopaminergic activity, they result in an unbalanced cholinergic activity. Benzhexol is a <strong>centrally acting&nbsp;</strong>antimuscarinic agent. It acts by restoring the cholinergic balance in the striatal interneurons.</p><p>The following drugs are implicated in drug-induced parkinsonism:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Drug class</strong></td>\n<td>\n<p><strong>Examples&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Typical antipsychotics</strong></td>\n<td>\n<p>Phenothiazines, haloperidol</p>\n</td>\n</tr>\n<tr>\n<td><strong>Atypical antipsychotics</strong></td>\n<td>Risperidone, olanzapine</td>\n</tr>\n<tr>\n<td><strong>Dopamine depleters</strong></td>\n<td>Reserpine, tetrabenazine</td>\n</tr>\n<tr>\n<td><strong>Antiemetics</strong></td>\n<td>Metoclopramide, levosulpiride</td>\n</tr>\n<tr>\n<td><strong>Calcium channel blockers</strong></td>\n<td>Flunarizine, cinnarizine</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Extrapyramidal side effects of antipsychotic drugs</h3><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Adverse reactions</strong></span></div>\n</td>\n<td>\n<div><span><strong>Time of onset</strong></span></div>\n</td>\n<td>\n<div><span><strong>Features</strong></span></div>\n</td>\n<td>\n<div><span><strong>Treatment</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Acute dystonia</strong></span></div>\n</td>\n<td>\n<div class=\"p1\"><span>1 to 5 days</span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Spasm of muscles of tongue, face, neck, back</span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Diphenhydramine or benztropine</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Akathisia</strong></span></div>\n</td>\n<td>\n<div class=\"p1\"><span>5 to 60 days</span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Restlessness</span></div>\n</td>\n<td>\n<div><span><strong>Propranolol</strong>,<strong>&nbsp;</strong>lorazepam, diphenhydramine, benztropine</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Parkinsonism</strong></span></div>\n</td>\n<td>\n<div class=\"p1\"><span>5 to 30 days</span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Bradykinesia, rigidity, tremors</span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Dose reduction, change medication, antiparkinsonian agents</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Tardive dyskinesia</strong></span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Months to years</span></div>\n</td>\n<td>\n<div class=\"p1\">\n<div class=\"p1\"><span>Orofacial dyskinesia (may be reversible with early recognition and drug discontinuation)</span></div>\n</div>\n</td>\n<td>\n<div class=\"p1\"><span>VMAT-2 inhibitors <strong>valbenazine</strong> and <strong>deutetrabenazine</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Neuroleptic malignant syndrome</strong></span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Weeks to months</span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Extreme rigidity, fever, unstable blood pressure</span></div>\n</td>\n<td>\n<div class=\"p1\"><span><strong>Dantrolene</strong></span></div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2891",
      "difficulty": "medium"
    }
  ]
}